Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Wheatley

Showing results (31-40 of 145) with videos related to

Pageof 15
Sort By:
Circulation. Cardiovascular Interventions|August 15, 2024
Long Term Outcomes After Renal Revascularization for Atherosclerotic Renovascular Disease in the ASTRAL TrialHannah O'Keeffe, Darren Green, Aine de Bhailis, et al.
BMJ (Clinical Research Ed.)|June 22, 2002
Evaluating drug treatments for Parkinson's disease: how good are the trials?Keith Wheatley, Rebecca L Stowe, Carl E Clarke, et al.
Blood|April 26, 2007
FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemiaAdam J Mead, David C Linch, Robert K Hills, et al.
The Cochrane Database of Systematic Reviews|July 9, 2010
Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complicationsRebecca Stowe, Natalie Ives, Carl E Clarke, et al.
British Journal of Haematology|March 29, 2002
Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99David K H Webb, Sarah J Passmore, Ian M Hann, et al.
Archives of Disease in Childhood|August 10, 2012
Varicella postexposure prophylaxis in children with cancer: urgent need for a randomised controlled trialJessica Bate, Julia Chisholm, Roderick Skinner, et al.
Blood|August 4, 2005
No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trialsRosemary E Gale, Robert Hills, Panagiotis D Kottaridis, et al.
The Cochrane Database of Systematic Reviews|May 18, 2012
Bisphosphonates in multiple myeloma: a network meta-analysisRahul Mhaskar, Jasmina Redzepovic, Keith Wheatley, et al.
Parkinsonism & Related Disorders|January 12, 2015
Systematic review and meta-analysis of hydrocarbon exposure and the risk of Parkinson's diseaseOliver Palin, Clare Herd, Karen E Morrison, et al.
Parkinsonism & Related Disorders|September 12, 2015
Comparing results from long and short form versions of the Parkinson's disease questionnaire in a longitudinal studyCrispin Jenkinson, Carl Clarke, Richard Gray, et al.
Pageof 15

Showing results (31-40 of 145) with videos related to

Sort By:
Pageof 15
Circulation. Cardiovascular Interventions|August 15, 2024
Long Term Outcomes After Renal Revascularization for Atherosclerotic Renovascular Disease in the ASTRAL TrialHannah O'Keeffe, Darren Green, Aine de Bhailis, et al.
BMJ (Clinical Research Ed.)|June 22, 2002
Evaluating drug treatments for Parkinson's disease: how good are the trials?Keith Wheatley, Rebecca L Stowe, Carl E Clarke, et al.
Blood|April 26, 2007
FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemiaAdam J Mead, David C Linch, Robert K Hills, et al.
The Cochrane Database of Systematic Reviews|July 9, 2010
Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complicationsRebecca Stowe, Natalie Ives, Carl E Clarke, et al.
British Journal of Haematology|March 29, 2002
Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99David K H Webb, Sarah J Passmore, Ian M Hann, et al.
Archives of Disease in Childhood|August 10, 2012
Varicella postexposure prophylaxis in children with cancer: urgent need for a randomised controlled trialJessica Bate, Julia Chisholm, Roderick Skinner, et al.
Blood|August 4, 2005
No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trialsRosemary E Gale, Robert Hills, Panagiotis D Kottaridis, et al.
The Cochrane Database of Systematic Reviews|May 18, 2012
Bisphosphonates in multiple myeloma: a network meta-analysisRahul Mhaskar, Jasmina Redzepovic, Keith Wheatley, et al.
Parkinsonism & Related Disorders|January 12, 2015
Systematic review and meta-analysis of hydrocarbon exposure and the risk of Parkinson's diseaseOliver Palin, Clare Herd, Karen E Morrison, et al.
Parkinsonism & Related Disorders|September 12, 2015
Comparing results from long and short form versions of the Parkinson's disease questionnaire in a longitudinal studyCrispin Jenkinson, Carl Clarke, Richard Gray, et al.
Pageof 15